Mainz Biomed N.V. (NASDAQ: MYNZ) Stock Information | RedChip

Mainz Biomed N.V. (NASDAQ: MYNZ) Listen to this Section


$0.32
-0.0015 ( -0.47% ) 1.5M

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Market Data


Open


$0.32

Previous close


$0.32

Volume


1.5M

Market cap


$7.33M

Day range


$0.31 - $0.35

52 week range


$0.31 - $4.38

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 3 May 31, 2024
6-k Quarterly Reports 6 Apr 24, 2024
6-k Quarterly Reports 3 Apr 19, 2024
20-f Annual reports 121 Apr 09, 2024
6-k Quarterly Reports 15 Feb 23, 2024
6-k Quarterly Reports 93 Nov 16, 2023
6-k Quarterly Reports 9 Nov 15, 2023
6-k Quarterly Reports 2 Nov 13, 2023
6-k Quarterly Reports 2 Sep 13, 2023
6-k Quarterly Reports 86 Aug 15, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.